Recent Updates
Recently added Catalysts
ALGN Positive Sentiment

Align Technology Announces Second Quarter 2026 Financial Results

Wednesday, July 29, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Align Technology reported its Q2 2026 financial results, showing total revenues of $1,056.2 million. This represents a 1.5% increase sequentially and a 4.3% increase year-over-year. Despite the positive revenue growth, the company noted that total revenues were adversely affected by unspecified factors.
Price reaction · baseline $180.08 (2026-07-29 close) · hit after-hours · 2 other ALGN headline(s) in the window, move may be shared
day 0 close · peak
-3.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Total revenues increased by 4.3% year-over-year.
  • Sequential revenue growth of 1.5% indicates stability.
  • Align Technology continues to lead in digital orthodontics.

CONCERNS & RISKS

  • Total revenues were unfavorably impacted by certain factors.
  • Specific challenges affecting revenue growth were not detailed.

Full Press Release Details

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the second quarter ("Q2'26"). Q2'26 total revenues were $1,056.2 million, up 1.5% sequentially and up 4.3% year-over-year. Q2'26 total revenues were unfavorably imp

Frequently Asked Questions

What were Align Technology's Q2 2026 total revenues?

Align Technology's total revenues for Q2 2026 were $1,056.2 million.

How much did revenues increase year-over-year?

Revenues increased by 4.3% year-over-year in Q2 2026.

What was the sequential revenue growth for Q2 2026?

The sequential revenue growth for Q2 2026 was 1.5%.

What impact did certain factors have on revenues?

Total revenues were unfavorably impacted by unspecified factors.

ShareAdd on Google
Tags: ALGN Align Technology Q2 2026 financial results revenue growth Invisalign
Last updated: Jul 29, 2026

Biotech snapshot

Cash runway
$1103M liquidity · $0M/mo burn
Low dilution risk